PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 73 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $108,000 | -65.2% | 42,154 | -73.7% | 0.00% | -71.4% |
| Q2 2022 | $310,000 | -48.6% | 160,420 | -21.0% | 0.01% | -50.0% |
| Q1 2022 | $603,000 | -2.3% | 203,083 | +235.7% | 0.01% | +16.7% |
| Q2 2018 | $617,000 | -88.3% | 60,500 | -71.3% | 0.01% | -84.8% |
| Q3 2017 | $5,285,000 | +605.6% | 210,550 | +440.5% | 0.08% | +618.2% |
| Q1 2017 | $749,000 | +49.5% | 38,953 | +1.2% | 0.01% | +37.5% |
| Q3 2016 | $501,000 | – | 38,503 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 2,339,107 | $10,502,000 | 3.20% |
| Telemetry Investments, L.L.C. | 262,279 | $1,178,000 | 1.52% |
| Bruce & Co., Inc. | 1,443,312 | $6,480,000 | 1.30% |
| Omega Fund Management, LLC | 1,971,241 | $8,851,000 | 1.25% |
| Worth Venture Partners, LLC | 556,832 | $2,500,000 | 1.24% |
| Abingworth LLP | 1,041,131 | $4,654,000 | 1.13% |
| 1492 Capital Management LLC | 491,033 | $2,205,000 | 1.09% |
| CM Management, LLC | 300,000 | $1,347,000 | 1.02% |
| Trellus Management Company, LLC | 295,000 | $1,325,000 | 0.88% |
| GENERAL AMERICAN INVESTORS CO INC | 1,306,919 | $5,868,000 | 0.46% |